Credit Suisse Initiates Coverage on The Advisory Board Company to Outperform

Credit Suisse Initiates Coverage on The Advisory Board Company(NASDAQ:ABCO). The shares have been rated Outperform. The rating by Credit Suisse was issued on Jun 20, 2016.

In a different note, On May 12, 2016, SunTrust Robinson Humphrey said it Maintains its rating on The Advisory Board Company. In the research note, the firm Raises the price-target to $35.00 per share. The shares have been rated ‘Buy’ by the firm. On May 2, 2016, Avondale Partners said it Maintains its rating on The Advisory Board Company. In the research note, the firm Raises the price-target to $31.00 per share. The shares have been rated ‘Market Perform’ by the firm. On Apr 18, 2016, KeyBanc said it Downgrades its rating on The Advisory Board Company. The shares have been rated ‘Sector Weight’ by the firm.

The Advisory Board Company (ABCO) shares turned negative on Fridays trading session with the shares closing down -0.76 points or -2.13% at a volume of 5,00,887. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $35.19. The peak price level was also seen at $35.19 while the days lowest was $34.26. Finally the shares closed at $35. The 52-week high of the shares is $60.38 while the 52-week low is $18.87. According to the latest information available, the market cap of the company is $1,435 M.

The Advisory Board Company(ABCO) last announced its earnings results on May 5, 2016 for Fiscal Year 2016 and Q4.Company reported revenue of $200.74M. Analysts had an estimated revenue of $201.74M. Earnings per share were $0.46. Analysts had estimated an EPS of $0.39.

Several Insider Transactions has been reported to the SEC. On Jun 1, 2016, Kelt Kindick (director) purchased 5,000 shares at $32.81 per share price.Also, On Apr 18, 2016, Cormac F Miller (Chief Product Officer) sold 1,628 shares at $31.65 per share price.On Mar 22, 2016, Hoose Mary Van (Chief Talent Officer) sold 4,172 shares at $30.27 per share price, according to the Form-4 filing with the securities and exchange commission.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

The Advisory Board Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on The Advisory Board Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.